Dunhill Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Dunhill Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$791	Buy	+5	New	+$676	﹤0.01%	1050
2025 Q4	–	Sell	-50	Closed	-$5.01K	–	2048
2025 Q3	$5.01K	Hold	50	–	–	﹤0.01%	567
2025 Q2	$4.15K	Buy	+50	New	+$3.99K	﹤0.01%	569

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Dunhill Financial's XBI Position: Q2 2026 in Review

Dunhill Financial opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 5 shares worth $791. The stake represents ﹤0.01% of the portfolio and ranks #1050 among its holdings. This is a return to the name: Dunhill Financial previously reported a position in XBI as recently as Q3 2025.

Dunhill Financial first reported a position in XBI in Q2 2025 and has held it in 3 quarters since. The position peaked at $5.01K in Q3 2025. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Dunhill Financial held 5 shares of State Street SPDR S&P Biotech ETF worth $791 as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Dunhill Financial position in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1050 holding.
Dunhill Financial first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and has held it in 3 quarters since.
Dunhill Financial's State Street SPDR S&P Biotech ETF position peaked at $5.01K in Q3 2025.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.